Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 1965, 30, 3370-3376
https://doi.org/10.1135/cccc19653370

Anabolic transformation of a novel antimetabolite, 5-azacytidine, and evidence for its incorporation into ribonucleic acid

M. Jurovčík, K. Raška, Jr., Z. Šormová and F. Šorm

Crossref Cited-by Linking

  • Podolyan Yevgeniy, Rubin Yury V., Leszczynski Jerzy: An ab Initio Post-Hartree−Fock Comparative Study of 5-Azacytosine and Cytosine and Their Dimers with Guanine. J. Phys. Chem. A 2000, 104, 9964. <https://doi.org/10.1021/jp0015271>
  • Damon Lloyd E., Cadman Edwin C.: The metabolic basis for combination chemotherapy. Pharmacology & Therapeutics 1988, 38, 73. <https://doi.org/10.1016/0163-7258(88)90103-9>
  • Čihák Alois, Vesely̌ Jiří, Sǩoda Jan: Azapyrimidine nucleosides: metabolism and inhibitory mechanisms. Advances in Enzyme Regulation 1985, 24, 335. <https://doi.org/10.1016/0065-2571(85)90085-8>
  • Kelly Cecil J., Coles Eric, Gaudio Linda, Yesair David W.: Characterization of the urinary metabolites of 5-azacytidine in mice. Biochemical Pharmacology 1980, 29, 609. <https://doi.org/10.1016/0006-2952(80)90384-6>
  • Chan Kenneth K., Giannini Donald D., Staroscik James A., Sadee Wolfgang: 5-Azacytidine Hydrolysis Kinetics Measured by High-Pressure Liquid Chromatography and 13C-NMR Spectroscopy. Journal of Pharmaceutical Sciences 1979, 68, 807. <https://doi.org/10.1002/jps.2600680705>
  • Zedeck Morris S.: Incorporation of ψ-isocytidine, a new antitumour C-nucleoside, into mammalian RNA and DNA. Biochemical Pharmacology 1979, 28, 1440. <https://doi.org/10.1016/0006-2952(79)90453-2>
  • Veselý Jiří, Čihák Alois: 5-Azacytidine: Mechanism of action and biological effects in mammalian cells. Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors 1978, 2, 813. <https://doi.org/10.1016/0362-5478(78)90016-5>
  • Drake James C., Stoller Ronald G., Chabner Bruce A.: Characteristics of the enzyme uridine-cytidine kinase isolated from a cultured human cell line. Biochemical Pharmacology 1977, 26, 64. <https://doi.org/10.1016/0006-2952(77)90132-0>
  • Lu Leejane Wang, Chiang Grace Han, Medina Daniel, Randerath Kurt: Drug effects on nucleic acid modification. I. A specific effect of 5-azacytidine on mammalian transfer RNA methylation invivo. Biochemical and Biophysical Research Communications 1976, 68, 1094. <https://doi.org/10.1016/0006-291X(76)90308-9>
  • Lee Thomas T., Karon Myron R.: Inhibition of protein synthesis in 5-azacytidine-treated HeLa cells. Biochemical Pharmacology 1976, 25, 1737. <https://doi.org/10.1016/0006-2952(76)90407-X>
  • Carter Stephen K., Slavik Milan: Investigational drugs under study by the United States National Cancer Institute. Cancer Treatment Reviews 1976, 3, 43. <https://doi.org/10.1016/S0305-7372(76)80016-3>
  • Weiss John W., Pitot Henry C.: Alteration of ribosomal precursor RNA in Novikoff hepatoma cells by 5-azacytidine. Archives of Biochemistry and Biophysics 1974, 165, 588. <https://doi.org/10.1016/0003-9861(74)90286-0>
  • Weiss John W., Pitot Henry C.: Inhibition of ribosomal ribonucleic acid maturation by 5-azacytidine and 8-azaguanine in Novikoff hepatoma cells. Archives of Biochemistry and Biophysics 1974, 160, 119. <https://doi.org/10.1016/S0003-9861(74)80016-0>
  • Reichman M., Penman S.: The mechanism of inhibition of protein synthesis by 5-azacytidine in HeLa cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1973, 324, 282. <https://doi.org/10.1016/0005-2787(73)90145-7>
  • Reichman M., Karlan D., Penman S.: Destructive processing of the 45-S ribosomal precursor in the presence of 5-azacytidine. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1973, 299, 173. <https://doi.org/10.1016/0005-2787(73)90409-7>
  • Chabner Bruce A., Drake James C., Johns David G.: Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase. Biochemical Pharmacology 1973, 22, 2763. <https://doi.org/10.1016/0006-2952(73)90137-8>
  • Carter Stephen K.: New drugs on the horizon in bronchogenic carcinoma. Cancer 1972, 30, 1402. <https://doi.org/10.1002/1097-0142(197211)30:5<1402::AID-CNCR2820300539>3.0.CO;2-N>
  • Fuǔík Vladimír, Michaelis Arnd, Rieger Rigomar: On the induction of segment extension and chromatid structural changes in Vicia faba chromosomes after treatment with 5-azacytidine and 5-azadeoxycytidine. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1970, 9, 599. <https://doi.org/10.1016/0027-5107(70)90105-3>
  • Doskocil J., Sorm F.: Incorporation and Phosphorylation of 5-Azacytidine by Normal and T4-Phage-Infected Cells of E. coli. Eur J Biochem 1969, 8, 75. <https://doi.org/10.1111/j.1432-1033.1969.tb00497.x>
  • Seifertová M., Veselý J., Šorm F.: Effect of 5-azacytidine on developing mouse embryo. Experientia 1968, 24, 487. <https://doi.org/10.1007/BF02144408>
  • Pačes V., Doskočil J., Šorm F.: Incorporation of 5-Azacytidine into nucleic acids of Escherichia coli. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1968, 161, 352. <https://doi.org/10.1016/0005-2787(68)90113-5>
  • Čihák A, Veselá H, Šorm F: Thymidine kinase and polyribosome distribution in regenerating rat liver following 5-azacytidine. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1968, 166, 277. <https://doi.org/10.1016/0005-2787(68)90518-2>
  • Veselý J., Čihák A., Šorm F.: Biochemical mechanism of drug resistance—VII. Biochemical Pharmacology 1968, 17, 519. <https://doi.org/10.1016/0006-2952(68)90267-0>
  • Veselý J., Čihák A., Šorm F.: Biochemical mechanisms of drug resistance IV. Development of resistance to 5‐azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice. Intl Journal of Cancer 1967, 2, 639. <https://doi.org/10.1002/ijc.2910020625>
  • Čihák A., Veselý J., Šorm F.: Complete inhibition by 5-azacytidine of hormonal induction of tryptophan pyrrolase. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1967, 134, 486. <https://doi.org/10.1016/0005-2787(67)90033-0>
  • Doskočil J., Pačes V., Šorm F.: Inhibition of protein synthesis by 5-azacytidine in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1967, 145, 771. <https://doi.org/10.1016/0005-2787(67)90136-0>
  • Doskočil J., Šorm F.: The action of 5-azacytidine on bacteria infected with bacteriophage T4. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1967, 145, 780. <https://doi.org/10.1016/0005-2787(67)90137-2>
  • Veselý J., Seifert J., Čihák A., Šorm F.: Biochemical changes associated with the development of resistance to 5‐azacytidine in AKR leukemic mice. Intl Journal of Cancer 1966, 1, 31. <https://doi.org/10.1002/ijc.2910010106>
  • Šorm F., Veselý J.: Partial reversal of toxic effects of 5-azacytidine by 6-azauridine in normal mice. Experientia 1965, 21, 581. <https://doi.org/10.1007/BF02151543>
  • Čihák A., Veselý J., Šorm F.: Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1965, 108, 516. <https://doi.org/10.1016/0005-2787(65)90046-8>